Genetic control of the clinical manifestation of leprosy was investigated in 66 unrelated pa tients with leprosy and 8 multiplex families. In 32 lepromatous leprosy(LL) patients, both phenotype frequency of HLA-DR2 and haplotype frequency of HLA-B35-DR2-DQwl were significantly increased. Our family data combined with other investigators' showed that the distribution of shared HLA haplotypes differed significantly from the random distribution, thereby suggesting the existence of an HLA-linked major gene for lepromatous leprosy. To investigate the function of this major gene, the cellular mechanism of nonresponsiveness of LL that is strictly specific to mycobacterium leprae (ML) antigen was analysed using pan ning technique and monoclonal antibodies. We have tested 30 LL patients for their suppres sive activity of T8 cells on the T cell response to ML of tuberculoid leprosy(TT) patients. T8 cells from two LL patients abrogated the response of TT patients. None of LL patients tested showed proliferative response to ML antigen even when we removed the T8 cells from the culture . Therefore, we concluded that nonresponsiveness to ML antigen of LL patients in vit ro were generated by the elimination of responding T cells. In the minor population of LL, T8 suppressor T cells were still active in peripheral blood. The T8 suppressor T cells might play some role in the elimination of responding T cells to ML antigen.
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To investigate the function of this major gene, we analysed the nonresponsiveness to ML antigen of LL patients . The immune responsiveness was measured by the T Iymphoprolifer ative response of peripheral blood lymphocytes (PBL) specific for soluble antigen in vitro . PBL from LL patients showed no response to ML antigen, whereas they showed good res ponse to other nominal antigens, such as purified protein derivatives (PPD), streptococcal cell wall antigen and candida albicans antigen (data not shown). These observations indicat ed that the nonresponsiveness to ML antigen of LL patients was antigen-specific. Furthermore , Figure I shows that the nonresponsiveness of LL was determined by T cells. The monocyte of LL presented ML antigen to T cells of TT patients. The T cells of LL did not show any response even in the presence of HLA-DR matched monocytes of TT . Antigen sp ecifi c nonresponsiveness of LL was determined by T cells, not by monocytes. We considered that the T cell dysfunction of LL was generated by fo llowing two alterna tives. One is the active suppression and the other is the clonal deletion.
Therefore , we have tested 30 LL patients for their suppressor activity of T8 cells or for their responsiveness of T4 cells. Out of 30 LL patients, 2 patients were positive for their suppressor activity of T8 cells ( Table 3 ). The immune response of PBL to ML antigen of HS (IT) (cpm = 50. 982) was abrogated by the addition of T cells or T8 cells of SK (LL) (96 .5 -100 % suppression). The other LL patients showed no response to ML antigen, even when we removed T8 cells from the culture.
From these observations we concluded that nonresponsiveness to ML antigen of LL pa tients in vitro were generated by the elimination of responding T cells, but that in the minor population of LL, T8 suppressor T cells were still active in peripheral blood.
The T8 suppressor T cells might play some role in the elimination of responding T cells to ML antigen during the long clinical course of LL. Further characterization of the suppres sion of T8 cells of LL including suppressor factor and the role of HLA is now under investi gation. 
